Abstract 2954: CS5007: A novel EGFR and HER3 dual-targeted antibody-drug conjugate (ADC) with potent antitumor activity in preclinical studies
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Chuan Wang, Yamin Wang, Ning Zhang, Xinling Zhang, Yongwang Li, Yuxin Qian, Yongli Yang, Mengyao Zhu, Xuelian Liu, Yaxin Chen, Fei Ma, Yi Sun, Jianxin Yang
Institution: CStone Pharmaceuticals (China)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629330